Add like
Add dislike
Add to saved papers

Differential regulation of tefluthrin and telmisartan on the gating charges of I Na activation and inactivation as well as on resurgent and persistent I Na in a pituitary cell line (GH 3 ).

Toxicology Letters 2018 March 16
Voltage-gated Na+ currents (INa ), known to contain many components (e.g., transient, resurgent and persistent INa ) with unique gating properties, are involved in the generation and propagation of action potentials in excitable cells. In this study, how tefluthrin (Tef), a synthetic pyrethoid, and telmisartan (TEL), blocker of angiotensin II receptors can perturb those components of INa was investigated. The presence of either Tef or TEL increased the values of the gating charges of INa involved in the activation (za ) and inactivation (zi ). Tef also increased the amplitude of resurgent INa (INa(R) ) or persistent INa (INa(P) ) in a pituitary cell line (GH3 ), while TEL produced minimal effects on them. Subsequent addition of either ranolazine (a blocker of late INa ) or d-limonene (a monoterpene), could reverse the changes by TEL or Tef on za or zi . In SCN5A-expressing HEK293T cells, addition of Tef or TEL also increased the peak amplitude and the inactivation time constant of INa which was accompanied by the increased za value of INa . Taken together, the results indicated that Tef- or TEL-mediated changes in the gating kinetics of INa are linked to their actions on functional activity of neurons, neuroendocrine or endocrine cells.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app